{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:28:37Z","timestamp":1786739317297,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"\n Background and Aims:<\/jats:title>\n Mass Drug Administration (MDA) coverage remains an important indicator in elimination of Lymphatic Filariasis (LF), especially in context of recent changes in programme strategies in India, such as incorporation of Ivermectin and involvement of urban Accredited Social Health Activists (ASHAs). This study aimed at assessing the coverage and compliance with MDA of Filariasis as well as exploring perspective of beneficiaries for non-consumption in selected slum area of Nagpur city.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Mixed-method study design comprising of quantitative assessment of MDA coverage, followed by qualitative method to explore the reasons of non-compliance was used in selected slum areas of Nagpur city. Using cluster sampling, 240 households were selected and house-to-house visits were made to interview the eligible participants. In-depth interviews were conducted among selected non-compliant participants.<\/jats:p>\n <\/jats:sec>\n \n Statistical Analysis:<\/jats:title>\n Multivariable logistic regression analysis to identify the factors associated with non-consumption. Thematic analysis was done to obtain the reasons of non-consumption as perceived by the beneficiaries.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Among the 1096 individuals studied, distribution and consumption coverage were 55.2% and 48.5%, respectively. Effective supervised consumption was further low (28.9%). Coverage compliance gap (CCG) was 12.1%. Male sex and younger age (2-5 years) were significant socio-demographic determinants of non-consumption. No repeat visit to houses left in first round, fear of side effects, pill burden, poor understanding about the need were important reasons as revealed by qualitative inquiry.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Effective pre-campaign awareness, incorporation of context specific drug delivery strategies and strengthening monitoring system are essential for successful MDA implementation.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_503_19","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:49:11Z","timestamp":1569890951000},"page":"3009-3014","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India"],"prefix":"10.4103","volume":"8","author":[{"given":"Sitikantha","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajari","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashshera F.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujiv","family":"Akkilagunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalaiselvi","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya P.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind S.","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-47-20260203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0169-4758(00)01643-4","article-title":"The economic burden of lymphatic filariasis in India","volume":"16","author":"Ramaiah","year":"2000","journal-title":"Parasitol Today Pers Ed"},{"key":"R13-47-20260203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/2394-7438.166306","article-title":"Mass drug administration program against lymphatic filariasis: Are we on the path to success? experience from Solapur District, Maharashtra","volume":"1","author":"Parande","year":"2015","journal-title":"MAMC J Med Sci"},{"key":"R14-47-20260203","first-page":"2105","article-title":"Evaluation of coverage and compliance of elimination of lymphatic filariasis by mass drug administration campaign in Gulbarga and Yadgiri districts of Karnataka state","volume":"3","author":"Havale","year":"2017","journal-title":"Int J Res Med Sci"},{"key":"R15-47-20260203","first-page":"25","article-title":"Mass drug administration coverage evaluation survey for lymphatic filariasis: An experience from Paschim Bardhaman District, West Bengal","volume":"50","author":"Banerjee","year":"2018","journal-title":"J Commun Dis"},{"key":"R16-47-20260203","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5455\/ijmsph.2015.08032015190","article-title":"Mass drug administration coverage evaluation for elimination of lymphatic filariasis in Chhatarpur district of Madhya Pradesh","volume":"4","author":"Marathe","year":"2015","journal-title":"Int J Med Sci Public Health"},{"key":"R17-47-20260203","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.18203\/2394-6040.ijcmph20173818","article-title":"Progress towards elimination of lymphatic filariasis in two districts of Maharashtra: Scenario of last five years","volume":"4","author":"Chaudhary","year":"2017","journal-title":"Int J Community Med Public Health"},{"key":"R18-47-20260203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.47203\/IJCH.2018.v30i03.017","article-title":"Mass drug administration (MDA) for elimination of lymphatic filariasis: Experiences from Nayagarh District of Odisha, India","volume":"30","author":"Bhatia","year":"2018","journal-title":"Indian J Comm Health"},{"key":"R19-47-20260203","first-page":"38","article-title":"An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat","volume":"33","author":"Kumar","year":"2008","journal-title":"Indian J Community Med Off Publ Indian Assoc Prev Soc Med"},{"key":"R22-47-20260203","first-page":"25","article-title":"Elimination of lymphatic filariasis: Current perspectives on mass drug administration","volume":"9","author":"Gyapong","year":"2018","journal-title":"Res Rep Trop Med"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_503_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:27:55Z","timestamp":1786735675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_503_19"}},"subtitle":["A mixed method study"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_503_19","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}